Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend
Bulletin Express
Jun 17
Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.
According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.
No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.